CASR and Hypocalcemia: A Bartter-like phenotype of these CASR activating mutations results in a presentation of hypokalemic metabolic alkalosis, with moderate secondary hyperaldosteronism without very severe salt loss, but with a tendancy for hypercalciuric hypocalcemia.